STOCK TITAN

Point72 and Steven Cohen report 1.3% Verastem (VSTM) stake in 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Verastem, Inc. received an amended ownership report from Point72 Asset Management, Point72 Capital Advisors and Steven A. Cohen, stating beneficial ownership of 995,026 common shares, or 1.3% of the company’s outstanding stock as of December 31, 2025. These shares are held through an investment fund managed by Point72 Asset Management, with voting and investment power shared among the reporting entities. The filers certify that the position is not held for the purpose of changing or influencing control of Verastem.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:02/17/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:02/17/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:02/17/2026
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

438.36M
11.68M
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM